Meeting Program

The 2025 Program Committee has been working hard on programming for our 2025 Annual Meeting. Here’s what to expect:

  • Four symposia
  • Four “Looking Back, Thinking Forward” sessions
    •  sessions include a 15-minute presentation by a senior scientist, followed by three short presentations selected from submitted abstracts, as well as time for questions/discussion 
  • “Best of ASPO” sessions
    •  32 high-ranking abstracts to be selected for 15-minute oral presentations. 
  • An invited keynote speaker
    • Dr. Kimryn Rathmell, NCI Director. The new NCI Director will discuss her vision and initial activities and investments in cancer prevention and control, including the Cancer Moonshot, the National Cancer Plan, the Cancer Screening Research Network, supporting diverse junior investigators, and more. 
  • Award lectures
  • SIG Breakfast Sessions
  • Networking lunch
  • 2 poster sessions

Advertisers, Sponsors, & Exhibitors

There are a variety of opportunities for advertisers, sponsors, and exhibitors for the 2025 Annual Meeting.

Carolyn Heckman, PhD
Rutgers Cancer Institute of New Jersey

Karen Wernli, PhD
Kaiser Permanente Washington Health Research Institute

Co-Chairs

2025 Program Committee

Dejana Braithwaite, PhD, MSc, University of Florida
Albert Farias, PhD, MPH, University of Southern California
Jessica Faupel-Badger, PhD, MPH, National Cancer Institute
Maria Eulalia Fernandez, PhD, UTHealth Houston SPH
Alison Herrmann, PhD, MS, UCLA
Anita Kinney, PhD, RN, Rutgers Cancer Institute of New Jersey
Lorna McNeill, PhD, MPH, UT MD Anderson Cancer Center
Suzanne O’Neill, PhD, Lombardi Cancer Center
Electra Paskett, PhD, The Ohio State University
Michael Scheurer, PhD, MPH, Baylor College of Medicine
Margauz Stack-Babich, MPH, UC San Diego
Parisa Tehranifar, DrPH, Columbia University
K. ‘Vish’ Viswanath, PhD, Dana Farber Cancer Institute
Shaneda Warren Andersen, PhD, University of Wisconsin-Madison
Nur Zeinomar, PhD, MPH, Rutgers Cancer Institute of New Jersey